(Q54062491)

24 May 2018

title

Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. (English)

1 reference

24 May 2018

6

J Lagacé

1 reference

24 May 2018

author name string

S Sachetelli

1

1 reference

24 May 2018

H Khalil

2

1 reference

24 May 2018

T Chen

3

1 reference

24 May 2018

C Beaulac

4

1 reference

24 May 2018

S Sénéchal

5

1 reference

24 May 2018

publication date

1 February 2000

1 reference

24 May 2018

Biochimica et Biophysica Acta

published in

1 reference

24 May 2018

volume

1463

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

254-266

1 reference

24 May 2018

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

1 reference

Management of pulmonary disease in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Prevention of drug access to bacterial targets: permeability barriers and active efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Inactivation of antibiotics and the dissemination of resistance genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Ins and outs of antimicrobial resistance: era of the drug pumps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Resistance to antibiotics mediated by target alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Protein AG-gold complex: an alternative probe in immunocytochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Use of resonance energy transfer to monitor membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

A cell line that can induce thymocyte positive selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Cell membrane labeling with fluorescent dyes for the demonstration of cytokine-induced fusion between monocytes and tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Membrane fusion: lipid vesicles as a model system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Liposomes fuse with sperm cells and induce activation by delivery of impermeant agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

Colloidal gold post-embedding immunocytochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2899%2900217-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2736(99)00217-5

1 reference

24 May 2018

PubMed ID

10675504

1 reference

24 May 2018